NOVARTIS AG DRN earnings per share and revenue

N1VS34 earnings per share for the last quarter are 13.03 BRL whereas the estimation was 12.08 BRL which accounts for 7.86% surprise. Company revenue for the same period amounts to 75.62 B BRL despite the estimated figure of 74.75 B BRL. Estimated earnings per share for the next quarter are 12.85 BRL, and revenue is expected to reach 77.97 B BRL. Also watch annual changes over time to get a bigger picture of N1VS34 earnings per share and revenue dynamics.